High uric acid blood levels, known as hyperuricemia, are closely associated with stone formation via the regulatory role of URAT1 and OAT1 regulatory transporters of urate in humans, recognized as key therapeutic targets for hyperuricemia. The gene discussed is SLC22A6; the disease is hyperuricemia.